HCP, Inc. (HCP) reported Q2 EPS of ($0.13), $0.19 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $125.3 million versus the consensus estimate of $111.09 million.
GUIDANCE:
HCP, Inc. sees Q3 2022 EPS of ($0.23)-($0.21), versus the consensus of ($0.30). HCP, Inc. sees Q3 2022 revenue of $123-125 million, versus the consensus of $119.93 million.
HCP, Inc. sees FY2022 EPS of ($0.71)-($0.69), versus the consensus of ($0.96). HCP, Inc. sees FY2022 revenue of $463-465 million, versus the consensus of $445.53 million.